Chronic Myelogenous Leukemia: Pregnancy in the Era of Stopping Tyrosine Kinase Inhibitor Therapy
Author:
Affiliation:
1. Ellin Berman, Memorial Sloan Kettering Cancer Center, New York, NY; Brian J. Druker, Oregon Health and Science Center, Portland, OR; and Richard Burwick, Cedars Sinai Medical Center, Los Angeles, CA
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2017.77.2574
Reference43 articles.
1. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
2. Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia
3. Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study
4. Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study
5. Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Outcome after short exposure to tyrosine kinase inhibitors in pregnant female patients with chronic myeloid leukemia;Journal of Hematology & Oncology;2024-09-11
2. Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study;Journal of Oncology Pharmacy Practice;2024-09-02
3. Male Fertility and Fatherhood in Chronic Myeloid Leukemia: Current Understanding and Future Perspectives;Cancers;2024-02-15
4. Acute leukemias in pregnant women: Results of a retrospective study at a local tertiary‐care hospital in Japan;eJHaem;2023-04-05
5. Family Planning and Pregnancy in Patients with Chronic Myeloid Leukemia;Current Hematologic Malignancy Reports;2023-02-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3